Changes in the expression of genes that regulate apoptosis as a factor in the development of chemoresistance in soft tissue sarcoma
Authors:
- T. I. FetisovTFT. I. Fetisov
- S. A. KhazanovaSKS. A. Khazanova
- P. A. ShtompelPSP. A. Shtompel
- E. S. TrapeznikovaETE. S. Trapeznikova
- A. A. TararykovaATA. A. Tararykova
- V. I. MarshallVMV. I. Marshall
- A. A. LowengerALA. A. Lowenger
- I. S. KupaevaIKI. S. Kupaeva
- D. V. RogozhinDRD. V. Rogozhin
- A. Yu. BokhyanABA. Yu. Bokhyan
- G. A. BelitskyGBG. A. Belitsky
Open Access
- 10 December 2024
- journal article
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 11 (4) , 80-92
Abstract
Introduction. The active use of highly toxic chemotherapy in the treatment of soft tissue sarcomas determines the need to search for criteria and markers of chemoresistance of patients to the therapy.Aim. To study the connection between tumor cell resistance to chemotherapy and expression levels of apoptosis-regulating proteins (PUMA, PMAIP-1, PIDD-1, AIFM-2, Bax, GADD45a) in primary cultures of soft tissue sarcomas.Materials and methods. Primary cultures of soft tissue sarcomas were obtained using enzymatic digestion, cell death was evaluated using resazurine assay. Gene expression was measured using real-time polymerase chain reaction, protein levels using immunoblotting assay.Results. 73 primary cultures of soft tissue sarcomas were obtained, for which chemosensitivity to doxorubicin, ifosfamide, docetaxel, gemcitabine, pazopanib and their combinations was determined using a resazurin cytotoxicity test. Associations of AIFM-2 gene expression with resistance to pazopanib, doxorubicin and its combination with ifosfamide were found in liposarcoma, synovial and undifferentiated pleomorphic sarcomas. In addition, associations between the expression of the Bax, PUMA, PMAIP-1, GADD45a and PIDD-1 genes and resistance to the studied drugs in various nosological subgroups of sarcomas were identified. When studying the amount of protein, it was revealed that undifferentiated pleomorphic and synovial sarcomas with a low content of GADD45a are more resistant to the studied drugs. Liposarcomas with high Bax expression are more resistant to docetaxel and gemcitabine, while synovial sarcomas with high Bax expression are more sensitive to doxorubicin and ifosfamide.Conclusion. The data obtained indicate a relationship between the activity of the studied genes-regulators of apoptosis and resistance to drugs used in the treatment of soft tissue sarcomas.Keywords
This publication has 28 references indexed in Scilit:
- Molecular mechanisms underpinning sarcomas and implications for current and future therapySignal Transduction and Targeted Therapy, 2021
- The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXACell Death & Disease, 2020
- BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancerCell Death & Differentiation, 2020
- Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanomaCell Death & Disease, 2020
- Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcomaScientific Reports, 2019
- Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue SarcomasCell, 2017
- Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapyBritish Journal of Cancer, 2016
- Assessment of Proliferation and Cytotoxicity in a Biomimetic Three-Dimensional Model of Lung CancerThe Annals of Thoracic Surgery, 2015
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialThe Lancet Oncology, 2014
- Insights into the regulation of protein abundance from proteomic and transcriptomic analysesNature Reviews Genetics, 2012